BioNexus Gene Lab (BGLC) Non-Current Assets (2018 - 2025)
Historic Non-Current Assets for BioNexus Gene Lab (BGLC) over the last 8 years, with Q3 2025 value amounting to $2.0 million.
- BioNexus Gene Lab's Non-Current Assets fell 4957.97% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.0 million, marking a year-over-year decrease of 4957.97%. This contributed to the annual value of $3.0 million for FY2024, which is 1042.63% down from last year.
- According to the latest figures from Q3 2025, BioNexus Gene Lab's Non-Current Assets is $2.0 million, which was down 4957.97% from $3.0 million recorded in Q2 2025.
- BioNexus Gene Lab's 5-year Non-Current Assets high stood at $4.0 million for Q3 2024, and its period low was $2.0 million during Q3 2025.
- Its 5-year average for Non-Current Assets is $2.8 million, with a median of $2.7 million in 2022.
- In the last 5 years, BioNexus Gene Lab's Non-Current Assets skyrocketed by 70639.04% in 2021 and then crashed by 4957.97% in 2025.
- BioNexus Gene Lab's Non-Current Assets (Quarter) stood at $2.4 million in 2021, then increased by 12.12% to $2.7 million in 2022, then rose by 23.35% to $3.4 million in 2023, then decreased by 10.43% to $3.0 million in 2024, then tumbled by 33.59% to $2.0 million in 2025.
- Its Non-Current Assets was $2.0 million in Q3 2025, compared to $3.0 million in Q2 2025 and $2.9 million in Q1 2025.